Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1aFrederik Barkhof, Maria A. Rocca, Gordon Francis et al.|Annals of Neurology|2003Cited by 135
Benefits of high-dose, high-frequency interferon beta-1a in relapsing–remitting multiple sclerosis are sustained to 16 months: Final comparative results of the EVIDENCE trialHillel Panitch, Brian G. Weinshenker, Peter Chang et al.|Journal of the Neurological Sciences|2005Cited by 98